Role of Macrophage Colony-Stimulating Factor for Staphylococcal Infection in the Oral Cavity

Overview

Journal J Clin Med

Specialty General Medicine

Date 2023 Sep 28

PMID 37762764

Authors

Hidenobu Senpuku

Kazuhisa Yoshimura

Hideki Takai

Yutaka Maruoka

Erika Yamashita

Akira Tominaga

Yorimasa Ogata

Affiliations

Soon will be listed here.

Abstract

Objective: There are few valid indicators of oral infection owing to the complexity of pathogenic factors in oral diseases. Salivary markers are very useful for scrutinizing the symptoms of disease. To provide a reliable and useful predictive indicator of infection for opportunistic pathogens in individuals with compromised immune systems, such as those with periodontal diseases and Human Immunodeficiency Virus (HIV), this study examines opportunistic pathogens such as and staphylococci and macrophage colony-stimulating factor (M-CSF) and CA125/MUC16 in saliva. The aim was to explore the correlations investigated among these factors.

Methods: Samples were divided into two groups (based on patient sex, the absence and presence of dentures in elderly, or HIV-positive patients and healthy subjects), and the correlation was analyzed in two groups of elderly patients with periodontal disease (64.5 ± 11.2 years old) and HIV-infected patients (41.9 ± 8.4 years old). Healthy subjects (33.8 ± 9.1 years old) were also analyzed as a control. Levels of , staphylococci, and M-CSF, which is an immunological factor for the differentiation of macrophage, and CA125/MUC16, which provides a protective lubricating barrier against infection, were investigated.

Results: A significant and positive correlation between the levels of M-CSF and staphylococci was found in elderly individuals and HIV-positive patients treated with antiretroviral therapy. A significant and positive correlation between the levels of M-CSF and CD125/MUC16 was also found in both patients. These correlations were enhanced in both patients as compared with healthy subjects.

Conclusion: Salivary M-CSF might be useful as a new indicator of opportunistic infection caused by staphylococci and a defense against infection in immunocompromised hosts.

References

Wu Z, Harne R, Chintoan-Uta C, Hu T, Wallace R, MacCallum A . Regulation and function of macrophage colony-stimulating factor (CSF1) in the chicken immune system. Dev Comp Immunol. 2019; 105:103586. PMC: 6996135. DOI: 10.1016/j.dci.2019.103586. View

Loster J, Wieczorek A, Loster B . Correlation between age and gender in species infections of complete denture wearers: a retrospective analysis. Clin Interv Aging. 2016; 11:1707-1714. PMC: 5123722. DOI: 10.2147/CIA.S116658. View

Mamedov M, Scholzen A, Nair R, Cumnock K, Kenkel J, Oliveira J . A Macrophage Colony-Stimulating-Factor-Producing γδ T Cell Subset Prevents Malarial Parasitemic Recurrence. Immunity. 2018; 48(2):350-363.e7. PMC: 5956914. DOI: 10.1016/j.immuni.2018.01.009. View

Roca F, Sepulcre M, Lopez-Castejon G, Meseguer J, Mulero V . The colony-stimulating factor-1 receptor is a specific marker of macrophages from the bony fish gilthead seabream. Mol Immunol. 2005; 43(9):1418-23. DOI: 10.1016/j.molimm.2005.07.028. View

Paquin-Proulx D, Greenspun B, Kitchen S, Raposo R, Nixon D, Grayfer L . Human interleukin-34-derived macrophages have increased resistance to HIV-1 infection. Cytokine. 2018; 111:272-277. DOI: 10.1016/j.cyto.2018.09.006. View

Zomorodian K, Haghighi N, Rajaee N, Pakshir K, Tarazooie B, Vojdani M . Assessment of Candida species colonization and denture-related stomatitis in complete denture wearers. Med Mycol. 2010; 49(2):208-11. DOI: 10.3109/13693786.2010.507605. View

Cenci E, Bartocci A, Puccetti P, Mocci S, Stanley E, Bistoni F . Macrophage colony-stimulating factor in murine candidiasis: serum and tissue levels during infection and protective effect of exogenous administration. Infect Immun. 1991; 59(3):868-72. PMC: 258340. DOI: 10.1128/iai.59.3.868-872.1991. View

Stanley E, Berg K, Einstein D, Lee P, Pixley F, Wang Y . Biology and action of colony--stimulating factor-1. Mol Reprod Dev. 1997; 46(1):4-10. DOI: 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V. View

Stanley E, Chen D, Lin H . Induction of macrophage production and proliferation by a purified colony stimulating factor. Nature. 1978; 274(5667):168-70. DOI: 10.1038/274168a0. View

10.

Weinke T, Schiller R, Fehrenbach F, POHLE H . Association between Staphylococcus aureus nasopharyngeal colonization and septicemia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1992; 11(11):985-9. DOI: 10.1007/BF01967787. View

11.

Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T . Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China. J Infect Dis. 2020; 222(5):746-754. PMC: 7337752. DOI: 10.1093/infdis/jiaa363. View

12.

Brook I, Frazier E . Aerobic and anaerobic microbiology of empyema. A retrospective review in two military hospitals. Chest. 1993; 103(5):1502-7. DOI: 10.1378/chest.103.5.1502. View

13.

Kalavi K, Jorjani O, Faghihi M, Mowla S . Cytokine Gene Expression Alterations in Human Macrophages Infected by . Cell J. 2020; 22(4):476-481. PMC: 7211285. DOI: 10.22074/cellj.2021.6524. View

14.

Gipson I, Spurr-Michaud S, Tisdale A, Menon B . Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function. PLoS One. 2014; 9(6):e100393. PMC: 4072602. DOI: 10.1371/journal.pone.0100393. View

15.

Gregory S, Wing E, Tweardy D, Shadduck R, Lin H . Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor. J Immunol. 1992; 149(1):188-93. View

16.

RAMFJORD S, Knowles J, Nissle R, Burgett F, Shick R . Results following three modalities of periodontal therapy. J Periodontol. 1975; 46(9):522-6. DOI: 10.1902/jop.1975.46.9.522. View

17.

Sweet M, Hume D . CSF-1 as a regulator of macrophage activation and immune responses. Arch Immunol Ther Exp (Warsz). 2003; 51(3):169-77. View

18.

Leigh J, Shetty K, Fidel Jr P . Oral opportunistic infections in HIV-positive individuals: review and role of mucosal immunity. AIDS Patient Care STDS. 2004; 18(8):443-56. DOI: 10.1089/1087291041703665. View

19.

Bedkowska G, Lawicki S, Gacuta E, Pawlowski P, Szmitkowski M . M-CSF in a new biomarker panel with HE4 and CA 125 in the diagnostics of epithelial ovarian cancer patients. J Ovarian Res. 2015; 8:27. PMC: 4426179. DOI: 10.1186/s13048-015-0153-3. View

20.

RAMFJORD S, Knowles J, Nissle R, Shick R, Burgett F . Longitudinal study of periodontal therapy. J Periodontol. 1973; 44(2):66-77. DOI: 10.1902/jop.1973.44.2.66. View